Ausgabe 4/2015
Inhalt (20 Artikel)
Platelet–endothelial cell interaction in brain microvessels of angiotensin II type-2 receptor knockout mice following transient bilateral common carotid artery occlusion
Takuya Fukuoka, Takeshi Hayashi, Makiko Hirayama, Hajime Maruyama, Masaki Mogi, Masatsugu Horiuchi, Masaki Takao, Norio Tanahashi
Preferences for anticoagulation therapy in atrial fibrillation: the patients’ view
Björn Böttger, Inga-Marion Thate-Waschke, Rupert Bauersachs, Thomas Kohlmann, Thomas Wilke
In vitro, antithrombotic and bleeding time studies of BMS-654457, a small-molecule, reversible and direct inhibitor of factor XIa
Pancras C. Wong, Mimi L. Quan, Carol A. Watson, Earl J. Crain, Mark R. Harpel, Alan R. Rendina, Joseph M. Luettgen, Ruth R. Wexler, William A. Schumacher, Dietmar A. Seiffert
Effectiveness and safety of thrombolytic therapy in elderly patients with pulmonary embolism
Göktürk İpek, Mehmet Baran Karataş, Tolga Onuk, Barış Güngör, Burcu Yüzbaş, Muhammed Keskin, Ozan Tanık, Ahmet Oz, Mert İlker Hayıroğlu, Osman Bolca
Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves
Jacqueline M. Schulman, Ammar Majeed, Eva Mattsson, Sam Schulman, Margareta Holmström, Anna Ågren
In-vitro thrombogenicity assessment of flow diversion and aneurysm bridging devices
Gaurav Girdhar, Junwei Li, Larisa Kostousov, John Wainwright, Wayne L. Chandler
Fructose induces prothrombotic phenotype in human endothelial cells
Plinio Cirillo, Grazia Pellegrino, Stefano Conte, Fabio Maresca, Francesco Pacifico, Antonio Leonardi, Bruno Trimarco
Endovascular infection following inferior vena cava (IVC) filter insertion
Amihai Rottenstreich, Rachel Bar-Shalom, Allan I. Bloom, Yosef Kalish
Platelet leukocyte aggregates and markers of platelet aggregation, immune activation and disease progression in HIV infected treatment naive asymptomatic individuals
Bongani B. Nkambule, Glenda Davison, Hayley Ipp
Prescription of enoxaparin is associated with decreasing pulmonary embolism mortality rate in Germany
Carolin Pütter, Olga von Beckerath, Hanna Maria Sobik, Holger Reinecke, Jürgen Stausberg, Knut Kröger
Anagrelide compared with hydroxyurea in essential thrombocythemia: a meta-analysis
Bethany Samuelson, Chatree Chai-Adisaksopha, David Garcia
Why so little progress in therapeutic thrombolysis? The current state of the art and prospects for improvement
Victor Gurewich
The changing characteristics of atrial fibrillation patients treated with warfarin
Andrew Putnam, Xiaokui Gu, Brian Haymart, Eva Kline-Rogers, Steve Almany, Jay Kozlowski, Gregory D. Krol, Scott Kaatz, James B. Froehlich, Geoffrey D. Barnes
Body mass index predicts major bleeding risks in patients on warfarin
Adedotun A. Ogunsua, Sunkaru Touray, Justin K. Lui, Tiffany Ip, Jorge V. Escobar, Joel Gore
Aspirin dosing in cardiovascular disease prevention and management: an update
Leila Ganjehei, Richard C. Becker
Consequences of treating false positive heparin-induced thrombocytopenia
Jacob Marler, Jessica Unzaga, Sundae Stelts, Carrie S. Oliphant
Heart failure and pulmonary arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia type 2
Juan Du, Yan Zhu, Yu-Lin Zhang, Sha Li, Jing Huang, Xiao-Hua Luo, Lin Liu
The contribution of apixaban renal clearance to total clearance
Charles Frost, Rebecca A. Boyd
Erratum to: The effect of dabigatran and rivaroxaban on platelet reactivity and inflammatory markers
Noa Zemer-Wassercug, Moti Haim, Dorit Leshem-Lev, Katia L. Orvin, Muthiah Vaduganathan, Ariel Gutstein, Ehud Kadmon, Aviv Mager, Ran Kornowski, Eli I. Lev